Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 476

1.

Survival and Subsequent Dispersal of Rice Sclerotial Disease Fungi, Rhizoctonia oryzae and Rhizoctonia oryzae-sativae, in Paddy Fields.

Guo Q, Kamio A, Sharma BS, Sagara Y, Arakawa M, Inagaki K.

Plant Dis. 2006 May;90(5):615-622. doi: 10.1094/PD-90-0615.

PMID:
30781138
2.

Current status of Neisseria gonorrhoeae cervicitis in pregnant women in Japan.

Suzuki S, Hoshi SI, Sekizawa A, Sagara Y, Tanaka M, Kinoshita K, Kitamura T.

PLoS One. 2019 Feb 7;14(2):e0211595. doi: 10.1371/journal.pone.0211595. eCollection 2019.

3.

The pocket-creation method facilitates colonic endoscopic submucosal dissection (with video).

Takezawa T, Hayashi Y, Shinozaki S, Sagara Y, Okada M, Kobayashi Y, Sakamoto H, Miura Y, Sunada K, Lefor AK, Yamamoto H.

Gastrointest Endosc. 2019 Feb 1. pii: S0016-5107(19)30065-3. doi: 10.1016/j.gie.2019.01.022. [Epub ahead of print]

PMID:
30716306
4.

Development of Lobular Panniculitis Long After Completing the Personalized Peptide Vaccine Therapy.

Uchida A, Kawasaki E, Tojikubo M, Tamai H, Sagara Y, Nakano Y, Uji Y, Masuda M, Yamaguchi T, Yutani S.

Am J Case Rep. 2018 Dec 27;19:1530-1535. doi: 10.12659/AJCR.912418.

5.

Discrepancy of glutamic acid decarboxylase 65 autoantibody results between RSR radioimmunoassay and enzyme-linked immunosorbent assay in patients with type 1 diabetes is related to autoantibody affinity.

Kawasaki E, Okada A, Uchida A, Fukuyama T, Sagara Y, Nakano Y, Tamai H, Tojikubo M, Koga N.

J Diabetes Investig. 2018 Dec 24. doi: 10.1111/jdi.12996. [Epub ahead of print]

6.

Mechanoresponsive, Luminescent Polymer Blends Based on an Excimer-Forming Telechelic Macromolecule.

Calvino C, Sagara Y, Buclin V, Haehnel AP, Del Prado A, Aeby C, Simon YC, Schrettl S, Weder C.

Macromol Rapid Commun. 2019 Jan;40(1):e1800705. doi: 10.1002/marc.201800705. Epub 2018 Nov 12.

PMID:
30417478
7.

Linked Color Imaging and Blue Laser Imaging for Upper Gastrointestinal Screening.

Osawa H, Miura Y, Takezawa T, Ino Y, Khurelbaatar T, Sagara Y, Lefor AK, Yamamoto H.

Clin Endosc. 2018 Nov;51(6):513-526. doi: 10.5946/ce.2018.132. Epub 2018 Nov 2.

8.

Unusual fluorescent photoswitching of imidazole derivatives: the role of molecular conformation and twist angle controlled organic solid state fluorescence.

Kundu A, Karthikeyan S, Sagara Y, Moon D, Anthony SP.

Phys Chem Chem Phys. 2018 Nov 7;20(43):27385-27393. doi: 10.1039/c8cp05355c.

PMID:
30357180
9.

Impact of Topoisomerase IIα, PTEN, ABCC1/MRP1, and KI67 on triple-negative breast cancer patients treated with neoadjuvant chemotherapy.

Guestini F, Ono K, Miyashita M, Ishida T, Ohuchi N, Nakagawa S, Hirakawa H, Tamaki K, Ohi Y, Rai Y, Sagara Y, Sasano H, McNamara KM.

Breast Cancer Res Treat. 2018 Oct 10. doi: 10.1007/s10549-018-4985-6. [Epub ahead of print]

PMID:
30306430
10.

Does integrated shimming improve lesion detection in whole-body diffusion-weighted examinations of patients with breast cancer?

Sasaki M, Tozaki M, Maruyama K, Benkert T, Murakami W, Yotsumoto D, Oosako S, Sagara Y.

Jpn J Radiol. 2018 Dec;36(12):736-743. doi: 10.1007/s11604-018-0781-9. Epub 2018 Sep 27.

PMID:
30264217
11.

A genome-wide association study identifies three novel genetic markers for response to tamoxifen: A prospective multicenter study.

Onishi H, Udagawa C, Kubo M, Nakamura S, Akashi-Tanaka S, Kuwayama T, Watanabe C, Takamaru T, Takei H, Ishikawa T, Miyahara K, Matsumoto H, Hasegawa Y, Momozawa Y, Low SK, Kutomi G, Shima H, Satomi F, Okazaki M, Zaha H, Onomura M, Matsukata A, Sagara Y, Baba S, Yamada A, Shimada K, Shimizu D, Tsugawa K, Shimo A, Hartman M, Chan CW, Lee SC, Endo I, Zembutsu H.

PLoS One. 2018 Aug 30;13(8):e0201606. doi: 10.1371/journal.pone.0201606. eCollection 2018.

12.

Development of reference material with assigned value for human T-cell leukemia virus type 1 quantitative PCR in Japan.

Kuramitsu M, Okuma K, Nakashima M, Sato T, Sasaki D, Hasegawa H, Umeki K, Kubota R, Sasada K, Sobata R, Matsumoto C, Kaneko N, Tezuka K, Matsuoka S, Utsunomiya A, Koh KR, Ogata M, Ishitsuka K, Taki M, Nosaka K, Uchimaru K, Iwanaga M, Sagara Y, Yamano Y, Okayama A, Miura K, Satake M, Saito S, Watanabe T, Hamaguchi I.

Microbiol Immunol. 2018 Oct;62(10):673-676. doi: 10.1111/1348-0421.12644.

PMID:
30125970
13.

Anticancer Effects of Green Tea and the Underlying Molecular Mechanisms in Bladder Cancer.

Miyata Y, Matsuo T, Araki K, Nakamura Y, Sagara Y, Ohba K, Sakai H.

Medicines (Basel). 2018 Aug 10;5(3). pii: E87. doi: 10.3390/medicines5030087. Review.

14.

Maspin mRNA expression in sentinel lymph nodes predicts non-SLN metastasis in breast cancer patients with SLN metastasis.

Umekita Y, Ohi Y, Iwaya O, Souda M, Sagara Y, Tamada S, Yotsumoto D, Tanimoto A.

Histopathology. 2018 Dec;73(6):916-922. doi: 10.1111/his.13718. Epub 2018 Sep 25.

PMID:
30035819
15.

Survival Outcomes of Retreatment with Trastuzumab and Cytotoxic Chemotherapy for HER2-Positive Recurrent Patients With Breast Cancer Who Had Been Treated with Neo/adjuvant Trastuzumab Plus Multidrug Chemotherapy: A Japanese Multicenter Observational Study.

Yamashiro H, Sawaki M, Masuda N, Okumura Y, Takano T, Tokunaga E, Saito T, Sagara Y, Yamazaki K, Kawaguchi Y, Lee T, Ozaki S, Yamagami K, Yamamoto N, Kuroi K, Suwa H, Ohtani S, Ito T, Yasuno S, Morita S, Ohno S, Toi M.

Breast Cancer (Auckl). 2018 Jul 5;12:1178223418786243. doi: 10.1177/1178223418786243. eCollection 2018.

16.

Effectiveness of neo-adjuvant systemic therapy with trastuzumab for basal HER2 type breast cancer: results from retrospective cohort study of Japan Breast Cancer Research Group (JBCRG)-C03.

Sagara Y, Takada M, Ohi Y, Ohtani S, Kurozumi S, Inoue K, Kosaka Y, Hattori M, Yamashita T, Takao S, Sato N, Iwata H, Kurosumi M, Toi M.

Breast Cancer Res Treat. 2018 Oct;171(3):675-683. doi: 10.1007/s10549-018-4873-0. Epub 2018 Jul 3.

PMID:
29971625
17.

High Consumption of Green Tea Suppresses Urinary Tract Recurrence of Urothelial Cancer via Down-regulation of Human Antigen-R Expression in Never Smokers.

Yasuda T, Miyata Y, Nakamura Y, Sagara Y, Matsuo T, Ohba K, Sakai H.

In Vivo. 2018 Jul-Aug;32(4):721-729. doi: 10.21873/invivo.11300.

18.

Fine-scale geographic clustering pattern of human T-cell leukemia virus type 1 infection among blood donors in Kyushu-Okinawa, Japan.

Sagara Y, Iwanaga M, Morita M, Sagara Y, Nakamura H, Hirayama H, Irita K.

J Med Virol. 2018 Oct;90(10):1658-1665. doi: 10.1002/jmv.25239. Epub 2018 Jul 10.

19.

Evaluation of Risk of Injury by Extravasation of Hyperosmolar and Vasopressor Agents in a Rat Model.

Shibata Y, Sagara Y, Yokooji T, Taogoshi T, Tanaka M, Hide M, Matsuo H.

Biol Pharm Bull. 2018;41(6):951-956. doi: 10.1248/bpb.b18-00105.

20.

Pathological significance and prognostic roles of densities of CD57+ cells, CD68+ cells, and mast cells, and their ratios in clear cell renal cell carcinoma.

Nakanishi H, Miyata Y, Mochizuki Y, Yasuda T, Nakamura Y, Araki K, Sagara Y, Matsuo T, Ohba K, Sakai H.

Hum Pathol. 2018 Sep;79:102-108. doi: 10.1016/j.humpath.2018.05.007. Epub 2018 May 19.

21.

Randomized phase II study of anastrozole plus tegafur-uracil as neoadjuvant therapy for ER-positive breast cancer in postmenopausal Japanese women (Neo-ACET BC).

Nakayama T, Sagara Y, Takashima T, Matsunami N, Masuda N, Miyoshi Y, Taguchi T, Aono T, Ito T, Kagimura T, Noguchi S.

Cancer Chemother Pharmacol. 2018 Apr;81(4):755-762. doi: 10.1007/s00280-018-3544-5. Epub 2018 Feb 21.

22.

Bi-weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST-STUDY).

Ohtani S, Nakayama T, Yoshinami T, Watanabe KI, Hara F, Sagara Y, Kawaguchi H, Higaki K, Matsunami N, Hasegawa Y, Takahashi M, Mizutani M, Morimoto T, Sato M, Itoh M, Morita S, Masuda N.

Breast Cancer. 2018 Jul;25(4):438-446. doi: 10.1007/s12282-018-0843-y. Epub 2018 Feb 12.

23.

[A Case of Solitary Lymph Node Recurrence Accompanied by Metachronous Multiple Lesion after Definitive Chemoradiotherapy for Esophageal Cancer].

Kawai K, Fujiwara A, Okamura H, Watanabe K, Sagara Y.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1217-1219. Japanese.

PMID:
29394586
24.

Stimuli-Responsive Dual-Color Photon Upconversion: A Singlet-to-Triplet Absorption Sensitizer in a Soft Luminescent Cyclophane.

Mase K, Sasaki Y, Sagara Y, Tamaoki N, Weder C, Yanai N, Kimizuka N.

Angew Chem Int Ed Engl. 2018 Mar 5;57(11):2806-2810. doi: 10.1002/anie.201712644. Epub 2018 Feb 13.

PMID:
29363244
25.

Rotaxanes as Mechanochromic Fluorescent Force Transducers in Polymers.

Sagara Y, Karman M, Verde-Sesto E, Matsuo K, Kim Y, Tamaoki N, Weder C.

J Am Chem Soc. 2018 Feb 7;140(5):1584-1587. doi: 10.1021/jacs.7b12405. Epub 2018 Jan 24.

26.

Erratum to immediate breast volume replacement using a free dermal fat graft after breast cancer surgery: multi-institutional joint research of short-term outcomes in 262 Japanese patients.

Kijima Y, Koriyama C, Fujii T, Hirokaga K, Ishigure K, Kaneko T, Kayano S, Miyamoto S, Sagara Y, Sakurai T, Sakurai T, Sotome K, Ueo H, Wakita K, Watatani M.

Gland Surg. 2017 Dec;6(6):756-757. doi: 10.21037/gs.2017.12.03.

27.

Simultaneous whole-body and breast 18F-FDG PET/MRI examinations in patients with breast cancer: a comparison of apparent diffusion coefficients and maximum standardized uptake values.

Sasaki M, Tozaki M, Kubota K, Murakami W, Yotsumoto D, Sagara Y, Ohi Y, Oosako S, Sagara Y.

Jpn J Radiol. 2018 Feb;36(2):122-133. doi: 10.1007/s11604-017-0707-y. Epub 2017 Nov 20.

PMID:
29159779
28.

Cost-effectiveness analysis of the introduction of S-1 therapy for first-line metastatic breast cancer treatment in Japan: results from the randomized phase III SELECT BC trial.

Shiroiwa T, Fukuda T, Shimozuma K, Mouri M, Hagiwara Y, Kawahara T, Ohsumi S, Hozumi Y, Sagara Y, Ohashi Y, Mukai H.

BMC Cancer. 2017 Nov 17;17(1):773. doi: 10.1186/s12885-017-3774-7.

29.

A Mini-Review of Reactive Oxygen Species in Urological Cancer: Correlation with NADPH Oxidases, Angiogenesis, and Apoptosis.

Miyata Y, Matsuo T, Sagara Y, Ohba K, Ohyama K, Sakai H.

Int J Mol Sci. 2017 Oct 22;18(10). pii: E2214. doi: 10.3390/ijms18102214. Review.

30.

Injury due to extravasation of thiopental and propofol: Risks/effects of local cooling/warming in rats.

Shibata Y, Yokooji T, Itamura R, Sagara Y, Taogoshi T, Ogawa K, Tanaka M, Hide M, Kihira K, Matsuo H.

Biochem Biophys Rep. 2016 Sep 19;8:207-211. doi: 10.1016/j.bbrep.2016.09.005. eCollection 2016 Dec.

31.

Paradigm Shift toward Reducing Overtreatment of Ductal Carcinoma In Situ of Breast.

Sagara Y, Julia W, Golshan M, Toi M.

Front Oncol. 2017 Aug 28;7:192. doi: 10.3389/fonc.2017.00192. eCollection 2017. Review.

32.

Effects of cytokines derived from cancer-associated fibroblasts on androgen synthetic enzymes in estrogen receptor-negative breast carcinoma.

Kikuchi K, McNamara KM, Miki Y, Moon JY, Choi MH, Omata F, Sakurai M, Onodera Y, Rai Y, Ohi Y, Sagara Y, Miyashita M, Ishida T, Ohuchi N, Sasano H.

Breast Cancer Res Treat. 2017 Dec;166(3):709-723. doi: 10.1007/s10549-017-4464-5. Epub 2017 Aug 22.

PMID:
28831645
33.

Trends in adjuvant therapies after breast-conserving surgery for hormone receptor-positive ductal carcinoma in situ: findings from the National Cancer Database, 2004-2013.

Sagara Y, Freedman RA, Wong SM, Aydogan F, Nguyen A, Barry WT, Golshan M.

Breast Cancer Res Treat. 2017 Nov;166(2):583-592. doi: 10.1007/s10549-017-4436-9. Epub 2017 Aug 3.

PMID:
28776282
34.

Proviral Features of Human T Cell Leukemia Virus Type 1 in Carriers with Indeterminate Western Blot Analysis Results.

Kuramitsu M, Sekizuka T, Yamochi T, Firouzi S, Sato T, Umeki K, Sasaki D, Hasegawa H, Kubota R, Sobata R, Matsumoto C, Kaneko N, Momose H, Araki K, Saito M, Nosaka K, Utsunomiya A, Koh KR, Ogata M, Uchimaru K, Iwanaga M, Sagara Y, Yamano Y, Okayama A, Miura K, Satake M, Saito S, Itabashi K, Yamaguchi K, Kuroda M, Watanabe T, Okuma K, Hamaguchi I.

J Clin Microbiol. 2017 Sep;55(9):2838-2849. doi: 10.1128/JCM.00659-17. Epub 2017 Jul 12.

35.

Interactions between inflammatory gene polymorphisms and HTLV-I infection for total death, incidence of cancer, and atherosclerosis-related diseases among the Japanese population.

Kairupan TS, Ibusuki R, Kheradmand M, Sagara Y, Mantjoro EM, Nindita Y, Niimura H, Kuwabara K, Ogawa S, Tsumematsu-Nakahata N, Nerome Y, Owaki T, Matsushita T, Maenohara S, Yamaguchi K, Takezaki T.

J Epidemiol. 2017 Sep;27(9):420-427. doi: 10.1016/j.je.2016.08.017. Epub 2017 May 30.

36.

Feasibility of Intraoperative Breast MRI and the Role of Prone Versus Supine Positioning in Surgical Planning for Breast-Conserving Surgery.

Mallory MA, Sagara Y, Aydogan F, DeSantis S, Jayender J, Caragacianu D, Gombos E, Vosburgh KG, Jolesz FA, Golshan M.

Breast J. 2017 Nov;23(6):713-717. doi: 10.1111/tbj.12796. Epub 2017 Mar 10.

37.

Mechano- and Thermoresponsive Photoluminescent Supramolecular Polymer.

Lavrenova A, Balkenende DW, Sagara Y, Schrettl S, Simon YC, Weder C.

J Am Chem Soc. 2017 Mar 29;139(12):4302-4305. doi: 10.1021/jacs.7b00342. Epub 2017 Mar 21.

PMID:
28293946
38.

Analysis of HTLV-1 proviral load (PVL) and antibody detected with various kinds of tests in Japanese blood donors to understand the relationship between PVL and antibody level and to gain insights toward better antibody testing.

Matsumoto C, Sagara Y, Sobata R, Inoue Y, Morita M, Uchida S, Kiyokawa H, Satake M, Tadokoro K.

J Med Virol. 2017 Aug;89(8):1469-1476. doi: 10.1002/jmv.24802. Epub 2017 Mar 14.

PMID:
28252206
39.

Breast cancer prevention strategies in lobular carcinoma in situ: A decision analysis.

Wong SM, Stout NK, Punglia RS, Prakash I, Sagara Y, Golshan M.

Cancer. 2017 Jul 15;123(14):2609-2617. doi: 10.1002/cncr.30644. Epub 2017 Feb 21.

40.

Circulating tumor cells as a prognostic marker for efficacy in the randomized phase III JO21095 trial in Japanese patients with HER2-negative metastatic breast cancer.

Iwata H, Masuda N, Yamamoto D, Sagara Y, Sato N, Yamamoto Y, Saito M, Fujita T, Oura S, Watanabe J, Tsukabe M, Horiguchi K, Hattori S, Matsuura Y, Kuroi K.

Breast Cancer Res Treat. 2017 Apr;162(3):501-510. doi: 10.1007/s10549-017-4138-3. Epub 2017 Feb 8.

PMID:
28181129
41.

CCL11 promotes migration and proliferation of mouse neural progenitor cells.

Wang F, Baba N, Shen Y, Yamashita T, Tsuru E, Tsuda M, Maeda N, Sagara Y.

Stem Cell Res Ther. 2017 Feb 7;8(1):26. doi: 10.1186/s13287-017-0474-9.

42.

Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.

Wong SM, Freedman RA, Sagara Y, Aydogan F, Barry WT, Golshan M.

Ann Surg. 2017 Mar;265(3):581-589. doi: 10.1097/SLA.0000000000001698.

PMID:
28169929
43.

Green Tea Polyphenol Induces Changes in Cancer-Related Factors in an Animal Model of Bladder Cancer.

Matsuo T, Miyata Y, Asai A, Sagara Y, Furusato B, Fukuoka J, Sakai H.

PLoS One. 2017 Jan 31;12(1):e0171091. doi: 10.1371/journal.pone.0171091. eCollection 2017.

44.

Significant Effect of Polymorphisms in CYP2D6 on Response to Tamoxifen Therapy for Breast Cancer: A Prospective Multicenter Study.

Zembutsu H, Nakamura S, Akashi-Tanaka S, Kuwayama T, Watanabe C, Takamaru T, Takei H, Ishikawa T, Miyahara K, Matsumoto H, Hasegawa Y, Kutomi G, Shima H, Satomi F, Okazaki M, Zaha H, Onomura M, Matsukata A, Sagara Y, Baba S, Yamada A, Shimada K, Shimizu D, Tsugawa K, Shimo A, Tan EY, Hartman M, Chan CW, Lee SC, Nakamura Y.

Clin Cancer Res. 2017 Apr 15;23(8):2019-2026. doi: 10.1158/1078-0432.CCR-16-1779. Epub 2016 Oct 19.

45.

Incidence of human T-lymphotropic virus 1 infection in adolescent and adult blood donors in Japan: a nationwide retrospective cohort analysis.

Satake M, Iwanaga M, Sagara Y, Watanabe T, Okuma K, Hamaguchi I.

Lancet Infect Dis. 2016 Nov;16(11):1246-1254. doi: 10.1016/S1473-3099(16)30252-3. Epub 2016 Aug 23.

PMID:
27567105
46.

Use of an over-the-scope clipping device for closure of a jejuno-sigmoid fistula: a case report with long-term follow-up.

Sagara Y, Shinozaki S, Yano T, Sakamoto H, Hayashi Y, Lefor AK, Yamamoto H.

Clin J Gastroenterol. 2016 Dec;9(6):369-374. Epub 2016 Sep 23.

PMID:
27664154
47.

The relationship between the expression of FOXA1 and GATA3 and the efficacy of neoadjuvant endocrine therapy.

Tanaka K, Tokunaga E, Yamashita N, Sagara Y, Ohi Y, Taguchi K, Ohno S, Okano S, Oda Y, Maehara Y.

Breast Cancer. 2017 May;24(3):384-392. doi: 10.1007/s12282-016-0714-3. Epub 2016 Jul 29.

PMID:
27473079
48.

Reply to K. Lin et al.

Sagara Y, Freedman RA, Mallory MA, Wong SM, Barry WT, Golshan M.

J Clin Oncol. 2016 Oct 1;34(28):3485-6. doi: 10.1200/JCO.2016.68.7723. Epub 2016 Jul 25. No abstract available.

PMID:
27458285
49.

MDCT features of strangulated ileus due to an appendix epiploica of the sigmoid colon: four cases and a review of the literature.

Sagara Y, Matsumoto S, Oga M, Hongo N, Kaneko N, Mori H.

Abdom Radiol (NY). 2016 Sep;41(9):1722-7. doi: 10.1007/s00261-016-0835-3. Review.

PMID:
27392744
50.

Prognostic and predictive impacts of tumor-infiltrating lymphocytes differ between Triple-negative and HER2-positive breast cancers treated with standard systemic therapies.

Hida AI, Sagara Y, Yotsumoto D, Kanemitsu S, Kawano J, Baba S, Rai Y, Oshiro Y, Aogi K, Sagara Y, Ohi Y.

Breast Cancer Res Treat. 2016 Jul;158(1):1-9. doi: 10.1007/s10549-016-3848-2. Epub 2016 Jun 3.

Supplemental Content

Loading ...
Support Center